4//SEC Filing
Dubovsky Filip 4
Accession 0001209191-23-058982
CIK 0001000694other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:00 PM ET
Size
8.8 KB
Accession
0001209191-23-058982
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Dubovsky Filip
President, R&D
Transactions
- Exercise/ConversionSwap
Restricted Stock Units
2023-12-14−2,833→ 0 total→ Common Stock (2,833 underlying) - Exercise/ConversionSwap
Common Stock
2023-12-14$5.69/sh+2,833$16,120→ 55,150 total - Tax PaymentSwap
Common Stock
2023-12-14$5.69/sh−1,368$7,784→ 53,782 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F2]The RSUs subject to this grant under the Plan vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment with the Company through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001977361
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 5:00 PM ET
- Size
- 8.8 KB